Er alimemazin et egnet søvnmiddel for barn?

Tidsskrift for den Norske Laegeforening

Volumn 128, Issue 19, 2008, Pages 2194-2196

  Slørdal, Lars ^a,b   Bramness, Jørgen G ^c  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c Nasjonalt Folkehelseinstitutt ^*

Author keywords

[No Author keywords available]

Indexed keywords

ALIMEMAZINE; HISTAMINE H1 RECEPTOR ANTAGONIST; HYPNOTIC SEDATIVE AGENT;

ADULT; ARTICLE; CHILD; DRUG USE; HUMAN; SLEEP DISORDER;

ADULT; CHILD; DRUG UTILIZATION REVIEW; HISTAMINE H1 ANTAGONISTS; HUMANS; HYPNOTICS AND SEDATIVES; SLEEP DISORDERS; TRIMEPRAZINE;

EID: 54449086168     PISSN: 00292001     EISSN: 08077096     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (23)

1. Brunton L. Goodman and Gilman's The pharmacological basis of therapeutics. New York: McGraw Hill, 2006.
2. Steinsvåg SK. Antihistaminer - til nytte og besvær. Tidsskr Nor Lægeforen 2006; 126: 2662-3.
3. Baselt R. Disposition of toxic dugs and chemicals in man. 7. utg. Foster City, CA: Chemical Toxicology Institute, 2004.
4. Sponheim S, Aune H, Gulliksen M et al. Pharmacokinetics of trimeprazine in children. Pharmacol Toxicol 1990; 67: 243-5.
5. Lingjærde O. Alimemazine (Vallergan) som sovemiddel i almenpraksis. Pilotforsøk og dobbeltblind sammenligning med placebo. Tidsskr Nor Lægeforen 1978; 98: 828-31.
6. Kayed K, Hansen T, Godtlibsen OB. Controlled clinical investigation of trimeprazine as a sleep-inducer in normal subjects. Eur J Clin Pharmacol 1977; 11: 163-7.
7. Ramchandani P, Wiggs L, Webb V et al. A systematic review of treatments for settling problems and night waking in young children. BMJ 2000; 320: 209-13.
8. Richman N. A double-blind drug trial of treatment in young children with waking problems. J Child Psychol Psychiatry 1985; 26: 591-8.
9. Simonoff EA, Stores G. Controlled trial of trimeprazine tartrate for night waking. Arch Dis Child 1987; 62: 253-7.
10. France KG, Blampied NM, Wilkinson P. A multiple-baseline, double-blind evaluation of the effects of trimeprazine tartrate on infant sleep disturbance. Exp Clin Psychopharmacol 1999; 7: 502-13.
11. France KG, Blampied NM, Wilkinson P. Treatment of infant sleep disturbance by trimeprazine in combination with extinction. J Dev Behav Pediatr 1991; 12: 308-14.
12. Mitchell V, Grange C, Black A et al. A comparison of midazolam with trimeprazine as an oral premedicant for children. Anaesthesia 1997; 52: 416-21.
13. SPC for Vallergan. www.legemiddelverket.no/custom/templates/ gzInterIFrame_1548.aspx (30.10.2007).
14. Loan WB, Cuthbert D. Adverse cardiovascular response to oral trimeprazine in children. Br Med J (Clin Res Ed) 1985; 290: 1548-9.
15. Mann NP. Trimeprazine and respiratory depression. Arch Dis Child 1981; 56: 481-2.
16. Chambers FA, O'Leary E, Gormley PK et al. Delayed profound respiratory depression after premedication with trimeprazine. Anaesthesia 1992; 47: 585-6.
17. Harling DW. Trimeprazine tartrate and convulsions. Anaesthesia 1995; 50: 97-8.
18. van Maldegem B, Smit L, Touw D et al. Neuroleptic malignant syndrome in a 4-year-old girl associated with alimemazine. Eur J Pediatr 2002; 161: 259-61.
19. Moyes DG. Malignant hyperpyrexia caused by trimeprazine. Case report. Br J Anaesth 1973; 45: 1163-4.
20. Kahn A, Blum D. Possible role of phenothiazines in sudden infant death. Lancet 1979; 2: 364-5.
21. Kahn A, Blum D. Phenothiazines and sudden infant death syndrome. Pediatrics 1982; 70: 75-8.
22. Martin J, Hiscock H, Hardy P et al. Adverse associations of infant and child sleep problems and parent health: an Australian population study. Pediatrics 2007; 119: 947-55.
23. Sanz EJ. Drug prescribing for children in general practice. Acta Paediatr 1998; 87: 489-90.